A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects with Partial Onset Seizures, Followed by an Open-Label Exte